Abstract
Abstract Up to 20% of patients with pilocytic astrocytoma (PA) experience a poor outcome. BRAF alterations and Fibroblast growth factor receptor 1 (FGFR1) point mutations are key molecular alterations in Pas, but their clinical implications are not established. We aimed ...
Cite
CITATION STYLE
APA
Becker, A. P., Scapulatempo-Neto, C., Carloni, A. C., Paulino, A., Sheren, J., Aisner, D. L., … Reis, R. M. (2015). KIAA1549. Journal of Neuropathology & Experimental Neurology, 74(7), 743–754. https://doi.org/10.1097/nen.0000000000000213
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free